A detailed history of Bayesian Capital Management, LP transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 45,682 shares of CLBT stock, worth $1.01 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
45,682
Holding current value
$1.01 Million
% of portfolio
0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.61 - $17.52 $530,368 - $800,348
45,682 New
45,682 $769,000
Q4 2023

Feb 14, 2024

BUY
$6.45 - $8.76 $85,140 - $115,632
13,200 New
13,200 $114,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.21B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.